Overview
SIPS surgery (Stomach Intestinal Pylorus‑Sparing surgery) is a bariatric (weight‑loss) procedure that combines a vertical sleeve gastrectomy with a distal intestinal bypass while preserving the pyloric valve. The operation is designed to achieve substantial weight loss and metabolic improvement while mitigating some of the nutritional deficiencies associated with more extensive malabsorptive procedures such as the traditional duodenal switch.
Historical Development
The technique was first described in the early 2010s by surgeons seeking a middle ground between purely restrictive procedures (e.g., sleeve gastrectomy) and highly malabsorptive operations (e.g., biliopancreatic diversion with duodenal switch). The acronym “SIPS” highlights the key technical elements: a reduced‑size stomach (sleeve), an intestinal limb bypass, and preservation of the pylorus.
Surgical Technique
| Step | Description |
|---|---|
| 1. Sleeve Gastrectomy | A vertical resection of approximately 80 % of the greater curvature, creating a tubular gastric sleeve. |
| 2. Intestinal Bypass | A short common channel (typically 300–350 cm) is created by measuring the ileum from the ileocecal valve proximally. A duodeno‑ileal anastomosis is performed, routing food from the gastric sleeve to the distal ileum. |
| 3. Pylorus Preservation | The pyloric sphincter is left intact, maintaining regulated gastric emptying and reducing the risk of dumping syndrome. |
| 4. Anastomosis | A hand‑sewn or stapled duodeno‑ileal connection is completed; the biliary and pancreatic secretions mix with ingested food in the common channel. |
| 5. Closure | Standard closure of mesenteric defects and verification of hemostasis. |
Indications
- Primary bariatric surgery for patients with a body mass index (BMI) ≥ 35 kg/m² with or without obesity‑related comorbidities.
- Revision of failed restrictive procedures (e.g., sleeve gastrectomy) when additional malabsorption is desired.
Contraindications
- Severe liver disease (e.g., cirrhosis) due to increased risk of postoperative hepatic decompensation.
- Active inflammatory bowel disease or prior extensive small‑bowel resection.
- Inability to attend lifelong nutritional follow‑up.
Outcomes
| Metric | Reported Range (peer‑reviewed studies, 2015‑2023) |
|---|---|
| % Excess Weight Loss (%EWL) at 1 year | 65 % – 80 % |
| Resolution of Type 2 Diabetes | 70 % – 85 % |
| Vitamin/ mineral deficiency (e.g., iron, B12) | Lower than traditional duodenal switch; still requires supplementation. |
| Reoperation rate (within 5 years) | 5 % – 10 % (often for anastomotic ulcer or obstruction). |
Advantages Compared with Traditional Procedures
- Pyloric preservation reduces rapid gastric emptying and associated symptoms.
- Shorter common channel than biliopancreatic diversion, decreasing the magnitude of protein‑calorie malabsorption.
- Simplified technique relative to a full duodenal switch, potentially shortening operative time.
Potential Complications
- Anastomotic leak or stenosis at the duodeno‑ileal connection.
- Nutritional deficiencies (fat‑soluble vitamins, trace minerals) requiring lifelong supplementation and monitoring.
- Bile reflux gastritis (rare).
- Gastro‑intestinal bleeding or ulceration.
Regulatory and Professional Status
- As of 2024, SIPS surgery is not specifically listed as an FDA‑cleared or FDA‑approved device or procedure; it is performed under the umbrella of “off‑label” bariatric surgery by surgeons trained in the technique.
- The American Society for Metabolic and Bariatric Surgery (ASMBS) acknowledges SIPS as an investigational procedure; it is included in clinical trial registries and case series but lacks large, randomized controlled trial data.
Post‑operative Care
- Nutritional supplementation: Multivitamin, calcium citrate with vitamin D, iron, vitamin B12, and protein (≥ 60 g/day).
- Follow‑up schedule: Visits at 2 weeks, 3 months, 6 months, and annually thereafter for weight, metabolic parameters, and nutrient levels.
- Lifestyle: Structured diet progression (liquids → pureed → solid) and regular physical activity.
Research Directions
- Ongoing prospective cohort studies aim to compare long‑term metabolic benefits of SIPS versus sleeve gastrectomy alone and versus duodenal switch.
- Randomized trials are limited; thus, high‑quality evidence regarding durability of weight loss and safety profile remains incomplete.
Conclusion
SIPS surgery is a hybrid bariatric operation that seeks to balance effective weight reduction with a reduced risk of severe malabsorption. While early clinical series demonstrate promising weight‑loss and comorbidity‑resolution outcomes, the procedure remains investigational, with limited long‑term data and no formal regulatory endorsement. Patients considering SIPS should be counseled on the need for lifelong medical follow‑up, nutritional supplementation, and the current evidence gaps.
